Stay updated with breaking news from Fibrocell Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
According to DelveInsight’s analysis, the growth of the gene therapies market in ophthalmology is expected to be mainly driven by the increasing prevalence of eye disease, rise in awareness and access to treatment, increased adoption of enhanced genetic testing and robust pipeline activity for eye disease in the 7MM. LAS VEGAS, April 4, 2024 /PRNewswire/ […]
/PRNewswire/ -- DelveInsight's Gene Therapies in Ophthalmology Market Insights report includes a comprehensive understanding of current treatment practices,...
/PRNewswire/ -- DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy...
Gene therapy clinical trial pipeline constitutes 250+ key companies continuously working towards developing 300+ gene therapies, analyzes DelveInsight LAS VEGAS, Nov. 2, 2022 /PRNewswire/
/PRNewswire/ -- DelveInsight's 'Gene Therapy Competitive Landscape – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...